Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 246

Showing 26-50 of 246 citing articles:

Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 30
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
Lysosomes as a Target of Anticancer Therapy
Wojciech Trybus, Ewa Trybus, Teodora Król
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2176-2176
Open Access | Times Cited: 26
Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance
Yongxia Zhu, Tong Xia, D Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101016-101016
Open Access | Times Cited: 23
Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options
Hongli Gao, Zhuo Xi, Jingwei Dai, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14
Image‐Guided Photothermal and Immune Therapy of Tumors via Melanin‐Producing Genetically Engineered Bacteria
Weijian Song, Yaling He, Ya‐Nan Feng, et al.
Small (2024) Vol. 20, Iss. 26
Open Access | Times Cited: 13
Anticancer drugs: How to select small molecule combinations?
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 503-519
Closed Access | Times Cited: 13
Mitogen signaling strength and duration can control cell cycle decisions
Ruth Nussinov, Wengang Zhang, Yonglan Liu, et al.
Science Advances (2024) Vol. 10, Iss. 27
Open Access | Times Cited: 13
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Doxorubicin loaded octacalcium phosphate particles as controlled release drug delivery systems: Physico-chemical characterization, in vitro drug release and evaluation of cell death pathway
Ilijana Kovrlija, Elżbieta Pańczyszyn, Öznur Demir, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123932-123932
Open Access | Times Cited: 12
Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?
Ravichandran Vishwa, Bandari BharathwajChetty, Sosmitha Girisa, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 293-319
Open Access | Times Cited: 12
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy
Chunbao Zang, Yu Tian, Yujing Tang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Peptide‐Functionalized Inorganic Oxide Nanomaterials for Solid Cancer Imaging and Therapy
Xiaolin Duan, Pin Wang, Lulu He, et al.
Advanced Materials (2024) Vol. 36, Iss. 37
Closed Access | Times Cited: 9
A comprehensive review of computational cell cycle models in guiding cancer treatment strategies
Chenhui Ma, Evren Gürkan-Çavusoglu
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
A second life for MAO inhibitors? From CNS diseases to anticancer therapy
Sabina Sblano, Angelina Boccarelli, Francesco Mesiti, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116180-116180
Open Access | Times Cited: 8
A Targeted and Responsive Nanoprodrug Delivery System for Synergistic Glioma Chemotherapy
Weiling Zhuo, Wanyu Wang, Wenjie Zhou, et al.
Small (2024) Vol. 20, Iss. 30
Closed Access | Times Cited: 8
mTOR Variants Activation Discovers PI3K-like Cryptic Pocket, Expanding Allosteric, Mutant-Selective Inhibitor Designs
Yonglan Liu, Wengang Zhang, Hyunbum Jang, et al.
Journal of Chemical Information and Modeling (2025)
Open Access | Times Cited: 1
Beyond small molecules: advancing MYC-targeted cancer therapies through protein engineering
Rama Edaibis, Raneem Akel, Jumi A. Shin
Transcription (2025), pp. 1-19
Closed Access | Times Cited: 1
Allostery, and how to define and measure signal transduction
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Biophysical Chemistry (2022) Vol. 283, pp. 106766-106766
Open Access | Times Cited: 36
Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance
Mjriam Capula, Macarena Perán, Geng Xu, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100864-100864
Open Access | Times Cited: 31
FADD as a key molecular player in cancer progression
Ying Liu, Xiaoge Li, Xuehao Zhou, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 29
Research progress on the anti-tumor effect of Naringin
Jing He, Huiping Zhang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis
Minglang Gao, Kai Lai, Yu Deng, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 10089-10104
Open Access | Times Cited: 19
Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/NRF2/GPX4 axis
Wenjie Huang, Fang Wen, Peipei Yang, et al.
Phytomedicine (2023) Vol. 123, pp. 155220-155220
Closed Access | Times Cited: 19

Scroll to top